Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 14, Issue 6, pp. 1376-1384
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 14, 2015
- Revision received March 24, 2015
- Accepted March 26, 2015
- Published first April 3, 2015.
Article Versions
- Previous version (April 3, 2015 - 09:05).
- Previous version (May 22, 2015 - 09:42).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Robert Chen1,*,
- Jessie Hou2,
- Edward Newman2,
- Young Kim3,
- Cecile Donohue2,
- Xueli Liu4,
- Sandra H. Thomas1,
- Stephen J. Forman1, and
- Susan E. Kane2
- 1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
- 2Department of Cancer Biology, City of Hope, Duarte, California.
- 3Department of Pathology, City of Hope, Duarte, California.
- 4Division of Biostatistics, Beckman Research Institute of City of Hope, Duarte, California.
- ↵*Corresponding Author:
Robert Chen, City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010. Phone: 626-256-4673, ext. 65298; Fax: 626-301-8116; E-mail: rchen{at}coh.org
June 2015
Volume 14, Issue 6
Volume 14, Issue 6
CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin
Jump to section
Advertisement